

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Primaquine serves as an effective antimalarial drug and a strong gametocytocide for falciparum malaria. It also prevents relapses in vivax and ovale malaria[1][2]. |
| 体内研究 | Primaquine (5-25 mg/kg; pO; daily; for 3 days) shows neither bioluminescence signal in the liver nor blood stage parasitemia[2]. |
| 体外研究 | Primaquine notably reduces the proliferation of viable breast cancer cells without affecting the growth of MCF-7 (ER+) and MDA-MB-453 (HER2+) cells. It impedes the proliferation, migration, and colony formation of breast cancer cells in vitro[3]. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01659281 | Plasmodium Falciparum Malaria | Not Applicable | Completed | - | Thailand ... 展开 >> Vector Borne Diseases Control Units (VBDC, malaria clinics) Borai, Khaosaming and Muang districts, Trat, Thailand, 23000 收起 << |
| NCT03726593 | Plasmodium Falciparum Malaria ... 展开 >>(Drug Resistant) 收起 << | Phase 4 | Recruiting | June 30, 2021 | Cambodia ... 展开 >> Kratie Referral Hospital Not yet recruiting Kratie, Cambodia Contact: Somaly Kieng, M.D +855 72 971 755 Contact: Chanthap Lon, M.D 855 23 881 845 chanthapl@afrims.org Sub-Investigator: Darapiseth Sea, MD Sub-Investigator: Dysoley Lek, MD Anlong Veng Referral Hospital Recruiting Ânlóng Vêng, Cambodia Contact: Phan Kong, M.A 016 51 09 09 Principal Investigator: Chanthap Lon, MD Sub-Investigator: Darapiseth Sea, MD Sub-Investigator: Dysoley Lek, MD 收起 << |
| NCT02528279 | Malaria | Not Applicable | Completed | - | Gabon ... 展开 >> Centre de Recherches Médicales de Lambaréné, Hôpital Albert Schweitzer Lambaréné, Moyen-Ogooué, Gabon, 118 Centre de Recherches Médicales de Ngounié Fougamou, Ngounié, Gabon, 113 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.86mL 0.77mL 0.39mL |
19.28mL 3.86mL 1.93mL |
38.56mL 7.71mL 3.86mL |
|
| CAS号 | 90-34-6 |
| 分子式 | C15H21N3O |
| 分子量 | 259.35 |
| SMILES Code | C2=C(C1=NC=CC=C1C=C2OC)NC(CCCN)C |
| MDL No. | MFCD00598906 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | INDBQLZJXZLFIT-UHFFFAOYSA-N |
| Pubchem ID | 4908 |
| 存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 |
| 溶解方案 |
DMSO: 250 mg/mL(963.96 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1